Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Int J Emerg Med ; 16(1): 47, 2023 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-37537558

RESUMEN

BACKGROUND: Female sex workers (FSW) in sub-Saharan Africa are disproportionately affected by HIV and remain a key target population for efforts to reduce transmission. While HIV prevention tools such as PEP and PrEP are available through outpatient FSW clinics, these services are underused. Emergency medicine is a rapidly expanding field in Kenya and may provide a novel venue for initiating or optimizing HIV prevention services. This study examined the characteristics of FSW from Nairobi, Kenya, who had utilized an emergency department (ED) during the past year to broaden our understanding of the patient factors related to usage. METHODS: An anonymous questionnaire was administered to a convenience sample of 220 Nairobi FSW attending dedicated clinics from June to July 2019. The participants were categorized into those who attended an ED over the past year (acute care users) and clinic-only users (control). A modified version of the WHO Violence Against Women Instrument assessed gender-based violence. Multivariable negative binomial logistic regressions evaluated predictors of health care use among these populations. RESULTS: Of the total 220 women (median [IQR] age 32 [27-39]), 101 and 116 were acute care and control populations, respectively. Acute care users had 12.7 ± 8.5 healthcare visits over a 12-month period, and the control population had 9.1 ± 7.0 (p < 0.05). ED attendance did not improve the PrEP usage, with 48.5%, and 51% of acute care and clinic users indicated appropriate PrEP use. Patient factors that correlated with health care utilization among acute care users included client sexual violence (OR 2.2 [1.64-2.94], p < 0.01), PrEP use (OR 1.54 (1.25-1.91), < 0.01), and client HIV status (OR 1.35 (1.02-1.69), p < 0.01). CONCLUSIONS: Many FSW at high risk for HIV were not accessing HIV prevention tools despite attending a dedicated FSW clinic offering such services. FSW who had attended an ED over the past year had a higher prevalence of HIV risk factors, demonstrating that emergency departments may be important acute intervention venues to prevent HIV transmission in this population. These results can guide policy design, health care provider training, and facility preparedness to support strategies aimed at improving HIV prevention strategies for FSW in Kenyan ED's.

3.
Pediatr Dermatol ; 39(6): 960-966, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35871636

RESUMEN

Pemphigus vulgaris (PV), an acquired autoimmune bullous disease, is caused by autoantibodies targeting desmosomal proteins in the skin and mucous membranes. Recent data from the adult PV population supports the use of rituximab, a chimeric anti-CD20 IgG1 antibody, as a primary treatment strategy, but limited data exist regarding treatment in the pediatric population. We report the case of a 13-year-old male with PV treated successfully with systemic corticosteroids and rituximab, and review the literature supporting the treatment of pediatric PV with rituximab.


Asunto(s)
Pénfigo , Masculino , Adulto , Niño , Humanos , Adolescente , Pénfigo/tratamiento farmacológico , Rituximab/uso terapéutico , Autoanticuerpos , Piel , Factores Inmunológicos/uso terapéutico
4.
J Obstet Gynaecol Can ; 44(2): 182-192, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34678521

RESUMEN

OBJECTIVES: The objectives of this study were to determine: 1) the prevalence of lichen sclerosus (LS) and lichen planus (LP) present in association with vulvar squamous cell carcinoma (VSCC), and 2) the incidence and absolute risk of developing VSCC in LS and LP. METHODS: A search was performed of MEDLINE, EMBASE and CINAHL databases. Three independent reviewers screened articles published before September 1, 2020, first on title/abstract and then on the full text. Women with a history of VSCC, human papillomavirus, smoking, or autoimmune disease were excluded. Newcastle-Ottawa observational study scales were used to assess the risk of bias and methodological quality of the included studies. Of the 3132 studies assessed, 31 were selected for analysis. Due to study heterogeneity, a qualitative synthesis was conducted. RESULTS: The prevalence of LS and LP in association with VSCC ranged from 0% (95% CI 0-5) to 83% (95% CI 36-100) and 1% (95% CI 0-7) to 33% (95% CI 4-78), respectively. The incidence of VSCC ranged from 1.16 (95% CI 0.03-6.44) to 13.67 (95% CI 5.50-28.17) per 1000 person-years for LS. The absolute risk of developing VSCC in patients ranged from 0.0% (95% CI 0.0-5.52) to 21.88% (95% CI 9.28-39.97) with LS and was 1.16% (95% CI 0.1-4.1) with LP. Incidence was not calculable for LP owing to study characteristics. CONCLUSIONS: This review provides evidence that there is an increased risk of developing VSCC in women with LS, while associations with LP are less clear. Early identification, treatment, and long-term follow-up are essential to prevent potential malignant progression of these vulvar dermatoses.


Asunto(s)
Carcinoma de Células Escamosas , Liquen Plano , Liquen Escleroso y Atrófico , Neoplasias de la Vulva , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Liquen Plano/complicaciones , Liquen Plano/epidemiología , Liquen Escleroso y Atrófico/complicaciones , Liquen Escleroso y Atrófico/epidemiología , Estudios Observacionales como Asunto , Vulva/patología , Neoplasias de la Vulva/epidemiología , Neoplasias de la Vulva/patología
5.
Emotion ; 21(7): 1570-1575, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34570558

RESUMEN

Nonverbal expressions of emotion can vary in intensity, from ambiguous to prototypical exemplars: for instance, facial displays of happiness may range from a faint smile to a full-blown grin. Previous work suggests that the accuracy with which facial expressions are recognized as the intended emotion increases with emotional intensity, although this pattern depends on the displayed emotion. Less is known about the association between emotional intensity and the recognition of vocal emotional expressions (affective prosody), which also convey information about others' socioemotional intent but are perceived and interpreted differently than facial expressions. The current study examined listeners' ability to recognize emotional intent in morphed vocal prosody recordings that varied in emotional intensity from neutral to prototypical exemplars of basic emotions (anger, disgust, fear, happiness, sadness) and social expressions (friendliness, meanness). Results suggest that listeners' accuracy in identifying the intended emotional intent in each recording increased nonlinearly with emotional intensity. This pattern varied by emotion type: for instance, accuracy for anger rose steeply with increasing emotional intensity before plateauing, whereas accuracy for happiness remained unchanged across low-intensity exemplars but increased thereafter. These findings highlight emotion-specific ways in which dynamic changes in emotional intensity inform perceptions of socioemotional intent in emotional prosody. Moreover, these results also point to potential challenges in emotional communication in social interactions that rely primarily on the voice, with many low-intensity expressions having a higher probability of being misinterpreted. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Asunto(s)
Reconocimiento en Psicología , Voz , Emociones , Expresión Facial , Felicidad , Humanos
6.
J Int AIDS Soc ; 24 Suppl 2: e25711, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-34164924

RESUMEN

INTRODUCTION: UNAIDS has identified female sex workers (FSW) as a key HIV at-risk population. FSW disproportionately experience gender-based violence, which compounds their risk of HIV acquisition and may contribute to adverse mental health outcomes. Pre-exposure prophylaxis (PrEP) is a powerful but underused HIV prevention tool for these women. This study explored the associations between intimate partner violence (IPV) and client-perpetrated violence against FSW, mental health outcomes and PrEP use. METHODS: An anonymous questionnaire was administered to a convenience sample of 220 Nairobi FSW attending dedicated clinics from June to July 2019, where PrEP was available free of charge. A modified version of the WHO Violence Against Women Instrument assessed IPV and client-perpetrated violence, and the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) assessed depressive and anxiety symptoms respectively. Multivariable logistic regressions evaluated predictors of depression, generalized anxiety and PrEP use. RESULTS: Of the total 220 women (median [IQR] age 32 [27-39]), 56.8% (125/220) reported depression (PHQ-9 ≥ 10) and 39.1% (86/220) reported anxiety (GAD-7 ≥ 10). Only 41.4% (91/220) reported optimal use of PrEP (taken correctly six to seven days/week) despite the cohort pursuing sex work for a median of 7 (4 to 12) years. Most women reported experiencing any violence in the past 12 months (90%, 198/220). Any recent IPV was frequent (78.7%, 129/164), particularly emotional IPV (66.5%, 109/164), as was any client-perpetrated violence in the past 12 months (80.9%, 178/220). Regression analyses found that violence was independently associated with depression (adjusted OR [aOR] 9.39, 95% CI 2.90 to 30.42, p = 0.0002) and generalized anxiety (aOR 3.47, 95% CI 1.10 to 10.88, p = 0.03), with the strongest associations between emotional IPV and both depression and anxiety. Recent client-perpetrated emotional violence (aOR 0.23, 95% CI 0.07 to 0.71, p = 0.01) was associated with decreased PrEP use, whereas client-perpetrated physical violence was associated with increased PrEP use (aOR 3.01, 95% CI 1.16 to 7.81, p = 0.02). CONCLUSIONS: There was a high prevalence of recent violence by different perpetrators as well as depression and anxiety among FSW from Nairobi. PrEP use was relatively infrequent, and recent client-perpetrated emotional violence was associated with PrEP non-use. Interventions to reduce gender-based violence may independently enhance HIV prevention and reduce the mental health burden in this community.


Asunto(s)
Infecciones por VIH , Violencia de Pareja , Profilaxis Pre-Exposición , Trabajadores Sexuales , Adulto , Ansiedad , Estudios Transversales , Depresión , Femenino , Infecciones por VIH/prevención & control , Humanos , Kenia/epidemiología , Factores de Riesgo , Violencia
7.
Skin Therapy Lett ; 26(3): 5-8, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-34077168

RESUMEN

Prurigo nodularis (PN) is a chronic, recalcitrant inflammatory skin condition characterized by the presence of pruritic nodules. The exact pathogenesis of the disease is unknown, although immune and neural dysregulation are indicated in driving the itchscratch cycle. Specifically, interleukin-4 and interleukin-31 pathways have been recently implicated in transmission of the pruritic sensation. There are currently no US FDA-approved targeted therapies for the treatment of PN. This article aims to review our present understanding of the disease pathogenesis and treatments, with a focus on emerging therapeutics. Specifically, this article explores the developing use of monoclonal antibodies nemolizumab and dupilumab, opioid receptor modulation and cannabinoids as potential treatments for PN.


Asunto(s)
Neurodermatitis , Prurigo , Anticuerpos Monoclonales/uso terapéutico , Humanos , Prurigo/tratamiento farmacológico
8.
Skin Therapy Lett ; 26(2): 1-5, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-33769772

RESUMEN

Psoriasis is a chronic, immune-mediated skin condition which commonly affects women of childbearing age. Certolizumab pegol (CZP) is an anti-tumor necrosis factor-alpha (anti-TNFα) agent that has demonstrated long-term safety and efficacy in treating moderate-to-severe plaque psoriasis. Previously, there has been limited safety data surrounding its use in pregnancy. The objective of this article is to review pivotal clinical trial data for CZP and explore safety considerations for this agent in pregnancy. This review demonstrates that CZP offers a safe and effective treatment option for women during childbearing years based on pharmacokinetics and available safety data. The observed occurrence of major congenital malformations and miscarriages appears to be no greater than the background occurrence of those in the general population, and risks to the mother are minimal based on its known safety profile. The use of CZP for treatment of plaque psoriasis should be considered and discussed with patients considering childbearing or whom are currently pregnant or breastfeeding.


Asunto(s)
Certolizumab Pegol/uso terapéutico , Inmunosupresores/uso terapéutico , Complicaciones del Embarazo/tratamiento farmacológico , Atención Prenatal , Psoriasis/tratamiento farmacológico , Certolizumab Pegol/efectos adversos , Femenino , Humanos , Inmunosupresores/efectos adversos , Embarazo
11.
Mol Genet Metab ; 108(3): 149-54, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23352389

RESUMEN

There is a compromised bone mass in phenylketonuria patients compared with normal population, but the mechanisms responsible are still a matter of investigation. In addition, tetrahydrobiopterin therapy is a new option for a significant proportion of these patients and the prevalence of mineral bone disease (MBD) in these patients is unknown. We conducted a cross-sectional observational study including 43 phenylketonuric patients. Bone densitometry, nutritional assessment, physical activity questionnaire, biochemical parameters, and molecular study were performed in all patients. Patients were stratified by phenotype, age and type of treatment. The MBD prevalence in phenylketonuria was 14%. Osteopenic and osteoporotic (n=6 patients) had an average daily natural protein intake significantly lower than the remaining (n=37) patients with PKU (14.33 ± 8.95 g vs 21.25 ± 20.85 g). Besides, a lower body mass index was found. There were no statistical differences in physical activity level, calcium, phosphorus and fat intake, and in phenylalanine, vitamin D, paratohormone, docosahexaenoic and eicosapentaenoic acid blood levels. Mutational spectrum was found in up to 30 different PAH genotypes and no relationship was established among genotype and development of MBD. None of the twelve phenylketonuric patients treated with tetrahydrobiopterin (27.9%), for an average of 7.1 years, developed MBD. Natural protein intake and blood levels of eicosapentaenoic acid were significantly higher while calcium intake was lower in these patients. This study shows that the decrease in natural protein intake can play an important role in MBD development in phenylketonuric patients. Therapy with tetrahydrobiopterin allows a more relaxed protein diet, which is associated with better bone mass.


Asunto(s)
Desmineralización Ósea Patológica/metabolismo , Enfermedades Óseas Metabólicas/metabolismo , Huesos/metabolismo , Proteínas en la Dieta/administración & dosificación , Minerales/administración & dosificación , Osteoporosis/metabolismo , Fenilcetonurias/metabolismo , Adolescente , Adulto , Biopterinas/análogos & derivados , Biopterinas/farmacología , Biopterinas/uso terapéutico , Índice de Masa Corporal , Desmineralización Ósea Patológica/complicaciones , Desmineralización Ósea Patológica/tratamiento farmacológico , Desmineralización Ósea Patológica/patología , Densidad Ósea/efectos de los fármacos , Enfermedades Óseas Metabólicas/complicaciones , Enfermedades Óseas Metabólicas/tratamiento farmacológico , Enfermedades Óseas Metabólicas/patología , Huesos/efectos de los fármacos , Huesos/patología , Calcio/metabolismo , Niño , Estudios Transversales , Ácido Eicosapentaenoico/metabolismo , Femenino , Humanos , Masculino , Actividad Motora , Mutación , Osteoporosis/complicaciones , Osteoporosis/tratamiento farmacológico , Osteoporosis/patología , Fenilalanina Hidroxilasa/genética , Fenilalanina Hidroxilasa/metabolismo , Fenilcetonurias/complicaciones , Fenilcetonurias/tratamiento farmacológico , Fenilcetonurias/patología , Factores de Riesgo , Encuestas y Cuestionarios
12.
Integr Environ Assess Manag ; 3(4): 517-28, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18046801

RESUMEN

The biotic ligand model (BLM) was used to assess copper (Cu) bioavailability, toxicity, water-effect ratios (WER), and Cu site-specific water-quality criteria (SSWQC) in the Matanza River and Pilcomayo River, Argentina, where anthropogenic inputs and natural phenomena have led to high concentrations of chemical species capable of reducing metal toxicity: Sodium, total hardness, alkalinity, dissolved organic carbon, and suspended particulate matter (SPM), as well as other metals. The purpose of this study was to evaluate the feasibility of developing Cu-SSWQC from a modified scenario of the BLM-Monte-Carlo method model. The response of the BLM model in these rivers, with water quality near its application boundary conditions, was evaluated during the 2003 to 2004 hydrological cycle. Cu toxicity tests were conducted with Daphnia magna as the test organism. The BLM (Version ap08) toxicity estimates for D. magna were within a factor of 2 of the line of perfect agreement with toxicity test results, although highly variable relevant water-quality parameters showed that mean estimates were more than 2 times the mean 50% effective concentration (EC50) derived from the corresponding toxicity tests. Suspended particulate matter was an important sink for Cu added to unfiltered water of the Pilcomayo River, but it also exerted some toxic effect. Minimums WER, estimated with a modified scenario of the BLM-MONTE, ranged from 1.5 (Pilcomayo River, at Misión La Paz) up to 11 (Matanza River, at Route 3). The corresponding Cu-SSWQC values were 30 and 105 microg/L, respectively.


Asunto(s)
Agua Dulce/análisis , Modelos Teóricos , Ríos , Argentina , Monitoreo del Ambiente/métodos , Geografía , Contaminantes Químicos del Agua/análisis
13.
Ginecol. obstet. Méx ; 64(4): 154-60, abr. 1996. tab, ilus
Artículo en Español | LILACS | ID: lil-181662

RESUMEN

El objetivo fue realizar el diagnóstico de confirmación-exclusión de hidrocefalia fetal, estudiar su etiología e identificar las anomalías asociadas. Se estudiaron 67 casos con diagnóstico de sospecha de hidrocefalia a una edad gestacional media de 30 semanas. Se efectuaron estudios seriados de ultrasonografía de alta definición, serología TORCH y estudio cromosómico del feto. Se realizó correlación diagnóstica de los resultados al nacimiento. La hidrocefalia se exluyó en 14 y se confirmó en 53. De éstos, 6 (11.3 por ciento) se clasificaron como hidrocefalia aislada y 47 (88.7 por ciento) con anomalías asociadas. En este grupo, 15 presentaron únicamente malformación intracraneana y 32, anomalías intra y extracraneanas combinadas así como las alteraciones cromosómicas identificadas. El diagnóstico de hidrocefalia se corroboró en todos los casos y el de anomalías asociadas en la mayoría de ellos. La hidrocefalia fetal se puede diagnósticar con certeza. El diagnóstico de anomalías asociadas presenta dificultades que se pueden reducir con las exploraciones ultrasonográficas seriadas y la participación multidisciplinaria


Asunto(s)
Humanos , Anomalías Congénitas , Cráneo/anomalías , Cefalometría , Ecocardiografía , Feto/anomalías , Hidrocefalia/diagnóstico , Hidrocefalia/etiología , Inmunoglobulina G/análisis , Inmunoglobulina M/análisis , Cariotipificación , Ultrasonografía Prenatal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA